UAB "Abbott Medical Lithuania" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 6,545,409 |
| 1,717,955 |
| 226,888 |
| 197,685 |
| 51,886 |
| 8.90 |
| 3.02 |
| 4,379,608 |
| 107,821 |
| 2,907 |
| 4,524,398 |
| 0.67 |
| 0.02 |
| - |
| - |
| 3.27 |
| 213,993 |
| 2023 |
|---|
| 6,539,792 |
| 1,634,948 |
| 316,496 |
| 277,945 |
| 69,486 |
| 13.12 |
| 4.25 |
| 1,757,553 |
| 102,062 |
| 28,784 |
| 2,050,049 |
| 0.26 |
| 0.06 |
| - |
| - |
| 3.90 |
| 255,144 |
| 2024 |
|---|
| 7,440,990 |
| 1,860,248 |
| 302,653 |
| 228,713 |
| 57,178 |
| 11.97 |
| 3.07 |
| 1,986,266 |
| 128,026 |
| 5,004 |
| 2,156,351 |
| 0.27 |
| 0.06 |
| - |
| - |
| 3.75 |
| 278,810 |
| 2024 |
|---|
| 7,440,990 |
| 1,860,248 |
| 302,653 |
| 228,713 |
| 57,178 |
| 11.97 |
| 3.07 |
| 1,986,266 |
| 128,026 |
| 5,004 |
| 2,156,351 |
| 0.27 |
| 0.06 |
| - |
| - |
| 3.75 |
| 278,810 |
Turnover (€)
2024
Turnover (€)
7,440,990 €14 % *
Sales per employee (€)
1,860,248 €14 % *
Profit before tax (€)
302,653 €-4 % *
Net Profit (€)
228,713 €-18 % *
Profit per employee (€)
57,178 €-18 % *
Total profitability (%)
11.97 %-8.77 % *
Net profitability (%)
3.07 %-27.76 % *
Equity (€)
1,986,266 €13 % *
Amounts Payable And Liabilities (€)
128,026 €25 % *
Non-current Assets (€)
5,004 €-83 % *
CurrentAssets (€)
2,156,351 €5 % *
Working capital requirement
0.27 3.85 % *
Debt-to-equity ratio
0.06 0.00 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
3.75 %-3.85 % *
EBIT (€)
278,810 €9 % *
